Table.2 Association of SUA parameters (SUA and SUA/SCr) with CKD and eTFG

SUA x CKD

  Q1 (2.60–4.30)

1

1

1

1

1

  Q2 (4.31–5.30)

2.48

(1.22–5.03)

3.32

(1.48–7.43)

3.27

(1.41–7.57)

3.16

(1.32–7.55)

1.86

(0.71–4.86)

  Q3 (5.31–6.30)

2.14

(1.02–4.49)

4.41

(1.83–10.62)

4.66

(1.88–11.55)

4.55

(1.76–11.72)

2.80

(0.99–7.91)

  Q4 (6.31–9.30)

4.95

(2.38–10.31)

16.37

(5.81–46.08)

17.90

(6.12–52.37)

18.71

(6.14–57.01)

6.72

(1.96–22.96)

SUA x eGFR

  Coefficient β

(CI 95 %)

-3.02

(-4.19 – -1.86)

-3.73

(-4.77 – -2.69)

-3.69

(-4.76 – -2.62)

-3.68

(-4.78 – -2.58)

-2.41

(-3.44 – -1.39)

SUA/SCr x CKD

  Q1 (1.72–4.48)

1

1

1

1

1

  Q2 (4.49–5.15)

1.05

(0.55–2.01)

0.99

(0.48–1.05)

0.94

(0.44–2.01)

0.96

(0.44–2.12)

0.93

(0.36–2.40)

  Q3 (5.16–6.06)

0.58

(0.29–1.12)

0.85

(0.40–1.82)

0.89

(0.41–1.93)

0.78

(0.34–1.75)

0.62

(0.23–1.67)

  Q4 (6.07–11.49)

0.34

(0.16–0.70)

0.38

(0.17–0.84)

0.38

(0.17–0.85)

0.37

(0.15–0.86)

0.38

(0.14–1.04)

SUA/SCr x eGFR

  Coefficient β

(CI 95 %)

3.74

(2.41–5.07)

3.07

(1.99–4.15)

3.12

(2.02–4.22)

3.29

(2.18–4.41)

2.39

(1.42–3.36)